Perioperative Pain Management for Lumbar Spine Surgery

Benha University

Status: Completed

Conditions: Pain, Postoperative

Treatments: Drug: Dexmedetomidine; Drug: Lidocaine Hydrochloride; Drug: Fentanyl Citrate

Study type: Interventional

Funder types: Other

Identifiers

NCT06662318

RC 22/10/2024

Details and patient eligibility

About

Perioperative pain management is crucial for patients undergoing elective lumbar spine surgery. Moderate to severe postoperative pain can significantly impact recovery, worsen patient outcomes, and potentially lead to chronic pain.

Opioids have traditionally been the mainstay of postoperative pain management. However, their use is associated with several adverse effects, including nausea, vomiting, respiratory depression, and the risk of developing chronic pain. To mitigate these risks, there is a growing emphasis on multimodal analgesic approaches that combine various non-opioid medications to provide effective pain relief.

Non-opioid analgesics, such as nonsteroidal anti-inflammatory drugs (NSAIDs), regional anesthesia techniques, and adjuvant medications, can be used to reduce opioid requirements and improve patient outcomes. By carefully selecting and combining these modalities, clinicians can optimize pain management strategies for individual patients, minimizing the need for opioids and their associated side effects.

Enrollment: 75 patients

Sex: All

Ages: 25 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who had LDD and required lumbar discectomy,
• Patients are free of exclusion criteria and accepted to participate in the study.

Exclusion criteria

• The presence of other indications for spinal surgery;
• Obesity of grade ≥II;
• Patients of ASA grade >II;
• opioid dependence for preoperative pain;
• The presence of other causes of preoperative pain;
• The presence of preoperative psychiatric manifestations especially delirium and/or cognitive dysfunction;
• The presence of contraindications for the use of the study drugs;
• The presence of uncontrolled cardiac, renal, or hepatic disorders and essential hypertension.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

75 participants in 3 patient groups

Group L

Active Comparator group

Treatment:

Drug: Lidocaine Hydrochloride

Group D

Active Comparator group

Treatment:

Drug: Dexmedetomidine

Group F

Active Comparator group

Treatment:

Drug: Fentanyl Citrate